Back

New pharmacological treatments for diabetes and chronic kidney disease: GLP-1 receptor agonists, SGLT-2 inhibitors and nonsteroidal aldosterone antagonists

5 May 2024 (10:00 - 10:30)
Organised by:
Seminar Presentation Part of: 4th Session Diabetes and the Heart Open Access Cardiovascular Prevention and Rehabilitation Course

About the speaker

Photo
Doctor Baris Gungor

Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Center, Istanbul (Turkiye)

2 More presentations in this session

Presentation thumbnail
Approaching the patient with multimorbidity: Diabetes, CKD and heart failure
Professor M. Kavousi (Rotterdam, NL)
Presentation thumbnail
Arterial hypertension as a major cardiovascular risk factor. What are the BP targets in different populations?
Professor M. Dolzhenko (Kiev, UA)

Access the full session

Session thumbnail
4th Session

The Event

Event poster

Cardiovascular Prevention and Rehabilitation Course

5 May 2024 10:00 CET
You may be interested in
thumbnail
Congress Presentation
Prevention of new-onset heart failure and renoprotective effect with sodium-glucose cotransporter 2 inhibitors in patients with chronic kidney disease
29 August 2025
thumbnail
Congress Session
A multidisciplinary approach to type 2 diabetes, obesity, and cardiovascular diseases: current evidence and a glimpse into the future
27 August 2023
thumbnail
Congress Session
Redefining mineralocorticoid receptor antagonism in cardio-kidney-metabolic syndrome: from evidence to innovation
18 May 2025
thumbnail
Congress Presentation
Sodium-glucose cotransporter-2 inhibitors and their combination with glucagon like peptide-1 receptor agonists improve endothelial glycocalyx and arterial stiffness in type-2 diabetes
28 August 2020

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources